Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filipa Costa

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Rheumatology (Oxford, England)|December 14, 2025
Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndromePedro Gaspar, Ana Rita Cruz-Machado, Ana Mafalda Abrantes, et al.
Rheumatology (Oxford, England)|January 24, 2026
Comment on: Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome: ReplyPedro Gaspar, Ana Rita Cruz-Machado, Ana Mafalda Abrantes, et al.
Cell Reports. Medicine|September 9, 2025
Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumorsRafaela Abrantes, Christopher Forcados, David J Warren, et al.
Cancer Cell|July 23, 2013
A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesisMassimo Masiero, Filipa Costa Simões, Hee Dong Han, et al.
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|June 4, 2025
Use of direct oral anticoagulants in patients with stroke transferred for thrombectomyAna Isabel Rodrigues, Inês V Carvalho, Carolina Sousa Fernandes, et al.
Annals of the Rheumatic Diseases|April 23, 2026
Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trialEsperanza Naredo, Otto Olivas-Vergara, Pablo E Borges, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Rheumatology (Oxford, England)|December 14, 2025
Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndromePedro Gaspar, Ana Rita Cruz-Machado, Ana Mafalda Abrantes, et al.
Rheumatology (Oxford, England)|January 24, 2026
Comment on: Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome: ReplyPedro Gaspar, Ana Rita Cruz-Machado, Ana Mafalda Abrantes, et al.
Cell Reports. Medicine|September 9, 2025
Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumorsRafaela Abrantes, Christopher Forcados, David J Warren, et al.
Cancer Cell|July 23, 2013
A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesisMassimo Masiero, Filipa Costa Simões, Hee Dong Han, et al.
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|June 4, 2025
Use of direct oral anticoagulants in patients with stroke transferred for thrombectomyAna Isabel Rodrigues, Inês V Carvalho, Carolina Sousa Fernandes, et al.
Annals of the Rheumatic Diseases|April 23, 2026
Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trialEsperanza Naredo, Otto Olivas-Vergara, Pablo E Borges, et al.
Pageof 6